Leiomyosarcoma of the parotid gland in an HIV-positive patient: therapeutic approach, clinical course and review of the literature

Journal of Chemotherapy

Volumn 21, Issue 2, 2009, Pages 215-218

  Berretta, M ^a   Zanet, E ^a   Taibi, R ^b   Martellotta, F ^a   Pavone, P ^b   Bearz, A ^a   Gobitti, G ^a   Ciancia, E M ^c   Canzonieri, V ^a   Tirelli, U ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c Oncology Department   (Italy)

Author keywords

Chemotherapy; HIV; Leiomyosarcoma; Parotid gland

Indexed keywords

ANTIRETROVIRUS AGENT; EPIRUBICIN; FLUORODEOXYGLUCOSE F 18; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE;

ADULT; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LEIOMYOSARCOMA; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROTID GLAND CANCER; PAROTIDECTOMY; POSITRON EMISSION TOMOGRAPHY;

EID: 67249145722     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2009.21.2.215     Document Type: Article

References (23)

1. Kang J, Levinson JA, Hitti IF. Leiomyosarcoma of the parotid gland: a case report and review of the literature. Head Neck 21 (1999), 168-171.
2. Luna MA, Tortoledo E, Ordonez G, Frankenthaler RA, Bat-sakis JG. Primary sarcomas of the salivary glands. Arch Oto-laryngol 1991; 117: 320-306.
3. Audair PL, Langloss JM, Weiss SW, Corio RL. Sarcoma and sarcomatoid neoplasms of the major salivary gland regions. Cancer 1986; 58: 1305-1315.
4. Joshi W, Gagnon GA, Chadwick EG et al. The spectrum of mucosa- associated lymphoid tissue lesions in pediatric patients infected with HIV: a clinicopathologic study of six cases. Am J Clin Pathol 1997; 107(5); 592-600 Ando M, Matsuzaki M, Murofushi T. Mucosa-associated tissue lymphoma presented as diffuse swelling of the parotid gland. Am J Otolaryng 2005; 26: 285-88
5. Boulanger E, meignin V, Baia M et al. Mucosa associated lymphoid tissue lymphoma in patients with human immunodeficiency virus infection. Br J Haem 2007, 140: 464-74
6. Carbone A, Gloghini A, Ferlito A. Pathological features of lymphoid proliferations of the salivary glands: lymphoepithelial sialadenitis versus low-grade B-cell lymphoma of the malt type. Ann Otol Rhinol Laryngol 2000, 109 (12 Pt 1): 1170-5
7. Ellis GL. Lymphoid lesions of salivary glands: malignant and benign. Med Oral Patol Oral Cir Bucal 2007; 12(7): E479-85
8. Suankratay C, Shuangshoti S, Mutirangura A et al. Epstein-Barr virus infection-associated smooth-muscle tumors in patients with AIDS. CID 2005; 40: 1521-1528
9. Deyrup AT, Lee VK, Hill CE et al. Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events. A clinicopathologic and molecular analysis of 29 tumors from 19 patients. Am J Surg Pathol 2006; 30(1): 75-82
10. Jenson HB, Montalvo EA, McClain KL et al. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma. J Med Virol 1999; 57: 36-46
11. Liebowitz D. Epstein-Barr virus - An old dog with new tricks. N Engl J Med 1995; 332: 55-67
12. Hill MA, Araya JC. Eckert MW et al. Tumor specific Epstein-Barr Virus infection is not associated with leiomyosarcoma in Human Immunodeficiency Virus negative individuals. Cancer 1997; 80(2): 204-210
13. Ashawani S, Sumit M, Deepika S, Mandal AK, Agarwal AK. Parotid gland leiomyosarcoma in a child: An extremely unusual neoplasm. Oral Surg., Oral med., Oral Path., Oral Rad.. and endocrinol; 2006; 102 (1): 82-84.
14. Zbaren P, Ruchti C. Leiomyosarcoma of the middle ear and temporal bone. Ann Otol Rhinol Laryngol. 1994; 103: 537-541.
15. Kruger S, Sommer K Leiomyosarcoma of the parotid gland: a case report. Eur Arch Otorhinolaryngol 2006; 263: 951-954
16. Parker SL, Tong T, Golden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996; 46: 5-27
17. Gaynor JJ, Tan CC, Casper ES, et al. Refinement of clin-ico-pathologic staging for localized soft tissue sarcoma of the ex-tremety: a study of 423 adults. J Clin Oncol 1992; 10: 1317-1329
18. Broders AC, Hargrave R, Meyerding HW et al. Pathological features of soft tissue fibrosarcoma with special reference to the grading of its malignancy. Surg Gynecol Obstet 1939; 69: 267-272
19. Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft tissue sarcomas of the extremities : prospective randomized evaluations of 1) limb-sparing surgery plus radiaton therapy compared with amputation and 2) the role of adjuvant chemotherapy. Ann Surg 1982; 196: 305-15.
20. Benjamin R, Wiernik PH, Bachur NR. Adryamicin: a new effective agent in the therapy of disseminated sarcomas. Med Pe-diatr Oncol 1975; 1:63-76
21. Antman KH, Ryan L, Elias A, et al. Response to ifosfamide and mesna, in previously treated patients with metastatic or unresectable sarcoma. J Clin Oncol 1989; 7: 126-31.
22. Maki GR, Wathen JK, Patel SR et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas. J Clin Oncol 2007; 25: 2755-2763.
23. Herida M, Mary-Krause M, Kaplan R et al. Incidence of non-AIDS-defining cancers before and during the highly active anti-retroviral therapy in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003; 15: 21 (18): 3447-53.